Search Results

Guidelines regarding BRAF . Abbreviation: mAb, monoclonal antibody. Disclosures: Dr. Messersmith has disclosed that he receives institutional grant/research support from Alexo Therapeutics, Inc.; D3 Pharma; Genentech, Inc.; Immunomedics; Incyte; Millennium

clinical management have not changed, though they have become more complicated with the development and even FDA approval of new drugs for this indication. Similarly, use of HCT has shifted with the development of novel therapeutics in leukemia and lymphoma

expectancy <10 years was challenged. This study has several limitations. First, the data on diagnosis, therapeutics, and outcome are very limited, and Gleason score, prostate-specific antigen level at diagnosis, detailed clinical stage and modality used for

of new therapeutics. Although oncology therapeutics undergo a stringent approval process under FDA regulations, older adults are inexplicably under-represented in registration trials. As of 1993, federal law has mandated that the NIH include and

new classes of antileukemia drugs and cellular therapeutics are fast becoming part of our ALL care strategy. These include therapeutics targeted at the expanding list of tumor-specific gene mutations and rearrangements that characterize the novel “Ph

The author participates in Speakers' Bureaus for Novartis Pharmaceuticals and Cell Therapeutics. References 1 Nowell PC Hungerford DA . A minute chromosome in human chronic granulocytic leukemia . Science 1960 ; 132 : 1497

through the NIH; to deny patients coverage for care at such facilities is to keep them away from programs that they built through financial support. It is also to deprive them of access to the emerging technologies and therapeutics that are reshaping

Medicine and Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of

the use of assay-directed therapy is from studies of the ChemoFx assay (Precision Therapeutics, Pittsburgh, Pennsylvania). Gallion et al. 10 evaluated the value of this chemosensitivity assay test for predicting progression-free interval in 135 women

Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as